Related Experiment Video

Updated: May 9, 2026

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

Proposal for generating new beta cells in a muted immune environment for type 1 diabetes

Claresa Levetan1, Paolo Pozzilli, Lois Jovanovic

  • 1Department of Endocrinology, Chestnut Hill Hospital, Philadelphia, PA, USA.

Diabetes/Metabolism Research and Reviews
|July 16, 2013
PubMed
Abstract

Insights

New trials explore combining Cyclosporine A with a beta cell regeneration agent for type 1 diabetes. This approach aims for sustained insulin-free remission in recent-onset patients.

Area of Science:

  • Immunology
  • Endocrinology
  • Regenerative Medicine

Background:

  • Immune tolerance agents show promise in mouse models but fail in human trials for type 1 diabetes.
  • Early trials with Cyclosporine A (CsA) in recent-onset type 1 diabetes yielded high initial remission rates.
  • Long-term follow-up revealed all patients eventually required insulin, suggesting a need for additional therapies.

Purpose of the Study:

  • To investigate the efficacy of a combination therapy for inducing long-lasting remission in recent-onset type 1 diabetes.
  • To evaluate the potential of a beta cell regeneration agent alongside an immune tolerance agent.

Main Methods:

  • A randomized, double-blind prospective trial design.
  • Participants include patients with recent-onset type 1 diabetes.
  • Intervention involves Cyclosporine A and a proton-pump inhibitor to increase gastrin levels.

Main Results:

  • The study is designed to assess the combined effect of immune modulation and beta cell regeneration.
  • Investigating the role of gastrin and Reg receptor pathways in pancreatic islet regeneration.

Conclusions:

  • Combination therapy may be necessary for sustained type 1 diabetes remission.
  • Further research is needed to explore novel therapeutic strategies for type 1 diabetes.
Keywords:
beta cell regenerationimmune protectiontype 1 diabetes

More Related Videos

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...